IGF2 and neoplasm: What is particularly interesting is that these same pathways and genes are upregulated in metastatic pancreatic neuroendocrine tumors [110], a tumor type that is presumed to have different tumor drivers than ileal NETs (e.g., MEN1 but not IGF2).